Mirtazapine added to SSRIs or SNRIs for treatment resistant depression in primary care: phase III randomised placebo controlled trial (MIR)
David Keßler(University of Bristol), Nicola Wiles, Simon Davies(Centre for Addiction and Mental Health), Chris Dickens(University of Exeter), Jeff Round(University College London), John Campbell(Northern Research Station), T. J. Peters(University Of Bristol Dental Hospital), Glyn Lewis(The London College), Mary Carter(University of Exeter), Ian Anderson(The University of Texas at Austin), William Hollingworth(At Bristol), Helen Gibson(Hull York Medical School), Stephanie MacNeill(University of Bristol), Una Macleod(University of Hull), Alison Burns, Carolyn Chew‐Graham(Keele University), Deborah Tallon, Caroline Jenkinson(University of Exeter)
Cited by 84
Related Papers
A Randomized Trial of Vertebroplasty for Osteoporotic Spinal Fractures
|New England Journal of Medicine|2009|1.4k
Controlled Interventions to Reduce Burnout in Physicians
|JAMA Internal Medicine|2016|1.3k
Preeclampsia and Future Cardiovascular Health
|Circulation Cardiovascular Quality and Outcomes|2017|1.1k
Model Transparency and Validation
|Medical Decision Making|2012|803